Levothyroxine Sodium Tablet
Product Images NDC 51655-578

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-578). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levothyroixe Molecule (Levothyroxine Molecule)

Levothyroixe Molecule (Levothyroxine Molecule)
Chemical structure of Levothyroxine Sodium depicted as a molecular diagram showing iodine-substituted aromatic rings, a hydroxyl group, and the sodium salt of an amino acid moiety with associated water molecule.*
FDA Label Image

Label (51655 578 52 Rev A 03 23 Nhc)

Label (51655 578 52   Rev A 03 23 Nhc)
Label for Levothyroxine Sodium Tablets, USP 200 mcg (0.2 mg) oral tablets. Package contains 30 tablets. The label includes storage instructions to keep between 15-30°C, protect from light and moisture, and keep out of reach of children. Produced by Northwind Health Company, LLC. Includes NDC 51655-578-52 and other regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.